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Fever is an adaptive response to a variety of infectious, inflammatory, and foreign stimuli. The 
“febrile response” confers an immunological advantage to the host over invading microorgan-
isms – bacterial, fungal and viral. Fever results from a cytokine-mediated reaction that results in 
the generation of acute phase reactants and controlled elevation of core body temperature. The 
anterior hypothalamus coordinates the “febrile response” in reaction to the release of endog-
enous pyrogenes and subsequent up-regulation of prostaglandin synthesis. An ensuing change 
in the hypothalamic set point for temperature regulation advances a synchronized physiologic 
response from CNS to periphery, on a microscopic and macroscopic level, throughout the entire 
human organism. This differs from hyperthermia which refers to heat retention attributable to 
unregulated readjustment of the thermoregulatory mechanism. Clinically, an elevation of core 
body temperature, whether in fever or hyperthermia, is only the most apparent manifestation 
of an intricate mechanism that orchestrates activation of autonomic, immunologic, neurologic, 
hematologic, endocrine and behavioral responses. 
Fever has been classically described as having three phases.1 In the “initiation phase,” cutaneous 
vasoconstriction diverts blood from the body’s surface to its core. Simultaneously, a broad 
sympathetic impulse commences rigors (shivering) as opposing muscles groups contract to 
contribute to excess heat production. The shunting of blood from epithelium to core organs 
and the increase in metabolic activity leads to the elevation of body temperature. In the “plateau 
phase,” heat production and heat loss equalize and the body maintains an elevated temperature 
through rigors and diaphoresis. In the third phase, or “defervescence,” cutaneous vasodilation 
and diaphoresis lead to dissipation and loss of excess heat, thus allowing the body temperature to 
drop back to normal. 
Hyperthermia occurs when there is disturbances to the central mechanisms of thermoregulation 
and heat dissipating mechanisms have been compromised. Although the exact mechanisms are 
unknown, “hyperthermia-induced brain injury” has been speculated to cause direct damage to 
thermoregulatory centers thus obliterating feedback to the temperature set point elevation.2 Some 
have hypothesized that brain injury induces disruption of mesencephalic-diencephalic physiology 
responsible for tonic inhibition of thermogenesis and the overriding effects of sympathetic 
activation which impair peripheral mechanisms of heat dissipation.3 Contrary to the normal 
processes associated with infectious fever, hyperthermia presents as an elevated body temperature 
in association with the absence of diaphoresis, tachypnea, and tachycardia.4 Other characteristics 
distinguishing hyperthermia from fever include: an inordinately high temperature (greater than 
41 C) that may persist for days to weeks, a lack of diurnal variation, a plateau-like pattern of 
elevations and maintenance.4 Interestingly, appropriate treatment hinges upon correct diagnosis of 
fever versus hyperthermia, as elevated temperature with hyperthermia is lowered more effectively 
by external cooling than by antipyretic agents. 
Although the causes of this phenomenon 
remain speculative, the neurologic effects of 
fever with traumatic brain injury, intracerebral 
hemorrhage, subarachnoid hemorrhage and 
post-operative recovery are significant – 
increased temperature has been associated 
with increased local cytokine activity, increased 
infarct size, increased intracranial pressure, 
vasospasm, symptomatic vasospasm, ischemic 
brain injury and poor outcomes in the acute 
phase of neurologic injury. 
Infectious Fever versus 
Non-Infectious Fever
In the NICU setting, fevers are classified as 
“infectious” or “non-infectious”.5 Clinicians 
further characterize them as either “explained” 
or “unexplained” according to clinical 
findings, laboratory tests, or imaging studies 
that elucidate their etiology.6 For example, 
pneumonia is an “explained” and “infectious” 
cause of fever, confirmed by leukocytosis, 
purulent tracheal secretion, positive sputum 
cultures and infiltrate on chest radiograph. On 
the other hand, atelectasis is an “explained” 
but “non-infectious” cause of fever confirmed 
by characteristic findings in two or more 
lung segments without leukocytosis or 
positive sputum cultures. Further still, 
central neurogenic fever or post-traumatic 
hyperthermia is an “unexplained” and “non-
infectious” cause of fever without confirmatory 
testing or sufficiently descriptive imaging 
studies. Central fever is speculated to result 
from damage to hypothalamus, midbrain, 
or pons enhanced by increased sympathetic 
activity, opening of the ventricles, damage to 
the frontal lobes, physical distortion, diffuse 
axonal injury, or toxic blood metabolites.8
Implication of Fever, both Infectious 
and Non-Infectious, in the NICU
In the critically-ill neurologic or neurosurgical 
patient, fever is a double-edged sword, char-
acterized by both beneficial and detrimental 
effects on the acutely injured central nervous 
system. The beneficial effects include enhanced 
resistance to infection, local activation of the 
coagulation cascade, cytokine-mediated T-cell 
activation, as well as, neutrophil and macro-
phage recruitment to injured tissues. In the 
critically-ill patient, the protective effect of fever 
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against the development of infection generally 
offset the dangers. Unfortunately, the patient 
that has suffered an acute insult to the CNS is 
an exception. After the initial injury, second-
ary brain insults are speculated to be caused 
by several processes including mitochondrial 
dysfunction, inflammatory response, free radi-
cal generation, and excitatory neurotransmitter 
release.9 These episodes of secondary brain 
injury appear to be caused by or temporally 
associated with hypotension, intermittent 
hypoxia and ischemia, fever and hyperther-
mia, cerebral hypertension and elevated intra-
cranial pressure.9
In terms of trauma to the CNS, it is commonly 
accepted that elevated temperature exacerbates 
secondary brain injury. Fever has been demon-
strated to increase glutamate release, provoke 
diffuse oxygen free radical production, increase 
cytoskeletal protein degradation, and mark-
edly augment the permeability of the blood-
brain barrier.10 Increased permeability allows 
activated immune cells to acquire increased 
access to the interstitial space. Furthermore, 
vasogenic edema leads to increased fluid in 
the extracellular space and accumulation of 
intracellular fluid resulting in cytotoxic edema. 
Despite evidence suggesting that hyperthermia 
does not impact the partial pressure of oxygen11 
or a causal relationship between elevated brain 
temperature and increased intracranial pres-
sure,12 current therapy suggests otherwise. 
Fever exacerbates ischemic neuronal damage 
and physiologic dysfunction after acute trau-
matic brain injury, subarachnoid hemorrhage, 
and major neurosurgery.13 In addition to the 
aforementioned effects, fever also increases 
circulating catecholamines boosting cardio-
vascular output to meet heightened metabolic 
demands, further taxing the already damaged 
CNS. In sum, the physiologic response to fever 
in the CNS has been assumed to contribute 
deleterious effects that exceed any potential 
benefits of staving off infection. 
Relevance to the Neurosurgical Patient
At least half of febrile incidents in the ICU are 
of non-infectious origin5 In the neurocritical 
and neurosurgical patients the incidence and 
prevalence of non-infectious fever are even 
greater. Febrile episodes occur in roughly 50% 
of patients in the NICU with neurocritical 
patients having a slightly lower frequency of 
fever, approximately 23%,6 than patients in the 
neurosurgical ICU, approximately 47%.14
Fever in the neurocritical and neurosurgical 
patient population predominates with vascular 
injuries, such as intracerebral hemorrhage and 
subarachnoid hemorrhage. The highest rates of 
febrile episode occur in patients with subarach-
noid hemorrhage (65%), followed by traumatic 
brain injury (40%) and intracranial hemorrhage 
(31%); no cause of fever was identified in 28% 
of patients, suggesting fever of central origin.6 
Fever has been linked to an increase in the 
length of stay, subsequent onset of further 
febrile episodes. Multiple studies have demon-
strated that “non-infectious fever” is common 
in both the neurocritical and neurosurgical ICU 
patient population. Fever also tends to predom-
inate amongst patients that have suffered either 
intracranial injury or traumatic brain injury as 
compared to spinal disorders. 
Infectious Fever in the NICU
A new fever in an ICU patient can have a 
multitude of infectious and non-infectious eti-
ologies. The practice guidelines from the Task 
Force of the Society for Critical Care Medicine 
(SSCM) and Infectious Disease Society of 
America (IDSA) urge for a “careful clinical 
assessment” and “cost-conscious approach” 
to obtaining a diagnosis through laboratory or 
radiological tests.15 The SSCM and IDSA Task 
Force recommend perpetual reflection on the 
impact of diagnostic testing and radiological 
imaging with respect to patient harm, further 
nosocomial infection risks, and the likelihood 
of legitimate life-sparing intervention. They 
argue that “infection be considered regardless 
of temperature but that laboratory tests for 
infection should be initiated for febrile patients 
only if clinical assessment indicates a reasonable 
possibility that infection might be present”.15
The common causes of infectious fever in a 
NICU patient are the same as those for any 
critically ill patient. However, specific con-
siderations should be made for nosocomoial 
infections secondary to depressed level of 
consciousness and surgical opening of the 
cranial vault. In a 2003 article, Commichau 
et al.6 reported that fever was associated with 
infection in 50% of the 387 patients admitted to 
the Columbia University Hospital NICU. In a 
European 2002 study, Stochetti et al.10 reported 
similar infection rates, again acknowledging 
pneumonia as the most frequent infection 
in head-injured patients. The most common 
infectious causes of fever in the NICU (10–20% 
of patients in the ICU) are presented in Table I.
The high incidence of nosocomial infections 
(NI) amongst patients admitted to Intensive 
Care Units (ICUs) are equally relevant 
to patients admitted to Neurocritical and 
Neurosurgical ICUs (NICUs). In the neuro-
critical and neurosurgical patient populations, 
nosocomial infection rates also depend on the 
severity of illness at presentation (i.e, Grade 
of SAH) and the exposure to invasive devices 
such as ventilators, central venous catheters 
and urinary catheters in addition to neuro-
science specific devices, such as ventricular 
catheters. In the U.S., nosocomial infection 
rates in ICUs are tracked by the “National 
Nosocomial Infections Surveillance” System 
(NNIS) run by and published annually by 
the CDC. Unfortunately, the NNIS does not 
collect or analyze data specific to the NICU 
setting, thus there is a paucity of data available 
on the incidence of NI in the neurocritical or 
neurosurgical patient population. 
In 1997, Dettenkofer et al.16 began a prospective 
study in a ten-bed NICU tracking the incidence 
of nosocomial infections over a 30-month study 
period. They reported data on 505 patients 
with a total of 4,873 patient days and 122 NI 
amongst 96 patients (74 patients with one NI, 
18 patients with two NI’s, 4 patients with three 
NI’s). The overall incidence of NI in the NICU 
was 24% (24.2 per 100 patients with a incidence 
density of 25.0 per 1,000 patient days), with 
nosocomial pneumonia (11.7%) and urinary 
tract infections (8.7%) the most frequent cause 
of infection, respectively. Interestingly, of the 
59 nosocomial pneumonias, only 22 (37%) 
were ventilator-associated while 37 (63%) 
non-ventilator-associated. Contrary to data on 
medical-surgical ICUs, more than half the cases 
of nosocomial pneumonia were non-ventilator 
associated, which corresponds to decreased 
ventilator usage among NICU patients. 
Furthermore, the incidence of nosocomial 
pneumonias can probably be accounted for by 
the known high risk of aspiration pneumonia 
for patients with a depressed level of conscious-
ness. With respect to UTI’s, the incidence of 
NI’s were strongly associated with device utili-
zation (42 of 44 UTI’s were device-associated). 
The incidence of bloodstream infections and 
other catheter related infections (local infec-
tions) were relatively low when compared to 
the incidence of pneumonias and UTI’s (1.4% 
and 1.2%, respectively). Finally, the incidence of 
ventriculitis and meningitis were also extremely 
low (0.8% and 0.4%, respectively) when also 
compared to other NI’s.
Non-Infectious Fever in the NICU, 
Explained and Unexplained Etiology
The patient with classic protracted fever in the 
NICU setting requires a methodical approach. 
Given the ramifications, an infectious cause is 
always presumed and its etiology sought for 
any critically ill patient with new onset of fever 
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occurs in ~ 25% of mechani-
cally ventilated medical-surgical 
ICU patients; Pulmonary infec-
tions (bronchitis and pneumonia) 
accounted for 82% of all infections 
and were the predominant cause 
of fever in patients with stroke; 
leukocytosis, purulent tracheal 
secretions, purulent sputum, 
decreased breath sounds, rales on 
rhonchi, new or worsening infil-
trates on chest radiograph
Chest imaging study—chest radio-
graph and/or CT scan (if otherwise 
indicated)
Cultures of secretions from LRTI 
before administration of antibiotic
Cultures: Epectorated sputum, 
tracheal secretions, broncheoal-
veolar lavage
In cases of co-morbid pleural  
effusion, thoracentesis if sufficient 
volume or juxtapositioned near 
lobar consolidation, stain, culture 
and cytology of pleural fluid
Bloodstream Infections: 
In absence of IV-line or catheters, 
bloodstream infections typically 
arise from gastrointestinal and 
genitourinary tracts flora.
Any new patient with fever; even 
when clinical findings do not 
strongly suggest a non-infectious 
cause, because positive culture 
has important prognostic and 
therapeutic implications
No more than three blood samples 
(10-15 ml each) for culture need to 
be drawn during the first 24 hours 
after fever onset, and two blood 
samples should generally suffice; 
draw at least two blood samples 
from separate venipuncture sites 




Stable catheters with good 
vascular access are a mainstay 
of treatment for the critically-ill.  
Infections caused by pathogens 
that have colonized an indwelling 
vascular device (tunneled, surgi-
cally implanted, cuffed central 
venous, or subcutaneous central 
venous port) can cause localized 
or systemic infection
Difficulty drawing or infusing 
through the catheter site, inflam-
mation at the insertion site; 
Recovery of microorganisms 
from the blood at multiple blood 
cultures; Rapid onset of infection 
associated with fulminant shock; 
Multiple positive blood cultures
Again, no more than three blood 
samples (10-15 ml each) for 
culture need to be drawn during 
the first 24 hours after fever onset, 
and two blood samples should 
generally suffice; draw at least 
two blood samples from separate 
venipuncture sites at least ten 
minutes apart using proper sterile 
techniques; infection at the insertion 
site as evidence by inflammation 
or purulence at the exit site or an 
intravascular site (cultures and 
thrombosis)
Sinusitis: 
Occurs in 5% of ICU patients, but 
with increased frequency in neuro-
surgical patients secondary to 
chronic intubation and NG tubes
Cough and leukocytosis with  
purulent nasal discharge, maxillary  
facial tenderness, periorbital 
edema, headache, tooth pain, 
earache, sorethroat, foul breath, 
wheezing
Remove nasotracheal or nasogastric 
tube placement, nasal packing, CT 
scan, coronal radiographs, or MRI, 
puncture and aspiration of sinuses 
under sterile conditions, gram stain 
and culture of organisms
Risk factors include facial  
fractures, steroid administration, 
NG/NT tubes, neurosurgery
Nosocomial Diarrhea: 
Most common febrile diarrhea 
in the ICU is Clostridium difficile; 
Antibiotic administration associ-
ated diarrhea (check medical 
record for previous use of 
Clindamycin or Cephalosporin or 
Fluoroquinolones)
2+ stools per day that conform to 
the container
Remove offending AB agent; diag-
nosis via “Gold Standard” is tissue 
culture from stool sample; Elisa 
Immunoassay test for toxins, Rapid 
C-Diff Test, gram stain and culture 
of organisms
Diarrhea is caused by enteral 
feeding, antibiotic overuse or 
infectious causes
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in NICU. However, there are equally legitimate 
noninfectious causes that must be considered 
as well. 
Avoidance of fever and hyperthermia remains 
a major aim in the management of patients in 
the NICU. However, this goal is not commonly 
achieved given the uncertain etiology of a 
potentially infectious or non-infectious fever. 
A fundamental principle in this setting is that 
the management of a classic fever of unknown 
origin is that “therapy should be withheld, 
whenever possible, until the cause of fever has 
been determined, so that it can be tailored to a 
specific diagnosis”. 7 
Within the non-infectious etiologies, there 
are four subcategories of non-Infectious fever 
which are the following:
1. Non-Infectious Inflammatory Disease: 
Autoimmune Diseases, Rheumatologic 
Phenomenon, 
2. Neoplastic Disease: 
Primary CNS Tumors and Malignancies, 
Leukemias and Lymphomas, Metastatic 
Disease, Oncologic Diseases
3. Pharmacologic Causes: 
Drug Fever, Withdrawal Syndromes, 
Neuroleptic Malignant Syndrome, 
Malignant Hyperthermia, Chemical 
Meningitis, Drug Toxicities
4. Post-Traumatic or Peri-Operative: 
Central Fever, Neurogenic Fever, Aseptic 
Meningitis, Atelectasis or ARDS without 
Pneumonia, Deep Venous Thrombosis, 
Posterior Fossa Syndrome
Fever is typical in a variety of acute and chronic 
neurological disorders confronted in the neu-
rocritical and neurosurgical patient popula-
tion. Copious experimental evidence suggests 
that fever is associated with neuronal injury in 
conditions such as cerebral ischemia, subarach-
noid hemorrhage, intracerebal hemorrhage, 
peri-operative neurosurgical recovery and 
traumatic brain injury. However, conclusive 
evidence linking control of non-infectious fever 
to improved outcomes has inherent difficulties 
because central neurogenic fever and post-
traumatic hyperthermia are diagnoses of exclu-
sion demanding a thorough previous infectious 
work-up. The impact of fever control in the 
NICU is at the mercy of a veteran clinician with 
a high index of suspicion because traditional 
methods of fever control are ineffective. 
Treatment Dilemma: “To treat or not 
to treat”
In NICU patients with fever, the clinical sign of 
pneumonia, bacteremia, sinusitis, UTI, or men-
ingitis or ventriculitis should direct the therapy 
and choice of an appropriate antibiotic rela-
tively immediately. First, all cultures should be 
obtained, while all central lines placed for >48 
hours and the nasal tube should be removed 
and cultured using semiquantitative or quan-
titative cultures. If fever persists for 48–96 
hours after antibiotic treatment and without 
the cause or source of the infection being 
identified, the patient should be reevaluated 
for risk factors associated with fungal infection 
(initiation of empiric antifungal treatment is 
indicated), while additional diagnostic test, 
including venography, CBC with differential 
and eosinophil count, and abdominal imaging 
are indicated. 
During recent years, several biomarkers have 
been proposed as adjunctive markers for the 
evaluation of fever, aiming to discriminate 
Table 1
Indication Work-Up Notes
Urinary Tract Infections: 
Urinary tract disease in the 
presence of bladder catheters, 
obstruction of the urethra, bladder 
or ureters, leukocyte esterase 
dipstick test
Pyuria, leukocytosis, purulent 
discharge from urethral meatus, 
obstructive symptoms, retention 
symptoms, suprapubic tenderness, 
costovertebral angle tenderness, 
change in mental status, fluid 
retention, edema, headache, 
change in mental status
Urine Culture (clean catch or urine 
port), remove pre-existing Foley 
catheter, gram stain or urinary 
sediment, and culture of organisms
Surgical Site Infections purulent discharge, tenderness, 
dehiscence, erythema, purulence, 
or tenderness
Examine surgical wound; Remove 
drains or packing, open the 
wound, aspirate under sterile 
conditions, irrigate; Gram stain and 
culture of organisms from pus or 
material deep within the wound site
CNS Infection Leukocytosis and alterations in 
neurological parameters, change 
in mental status, focal findings, 
absence of neurological findings, 
lateral shift of midline structures 
on imaging study, loss of supra-
chiasmatic and basilar cisterns, 
obliteration of the fourth ventricle
CT scan or MRI; Lumbar Puncture, 
determination of glucose, protein 
and LDH, Gram stain, white cell 
count and culture of CSF
Takes a high index of suspicion
continued
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between an infectious cause from a non-
infectious reaction or clandestine inflamma-
tory diseases. The biomarkers include: serum 
procalcitonin assays with variable cutoffs, 
endotoxin detection systems, triggering recep-
tor expressed on myeloid cells-S (TREM-1), 
C-reactive protein (CRP), tumor necrosis 
factor-α, and interleukin-6. From all the above 
biomarkers, serum procalcitonin assay is 
approved for early detection of bacterial infec-
tion/sepsis during the first day of ICU admis-
sion, while the rest have yet to be validated. 
The treatment of neurocritical or neurosurgical 
patients with central neurogenic fever hinges 
upon the axiomatic decision to declare a fever 
to be of infectious or non-infectious cause. For 
instance, to operate on the presumption that a 
patient has an infection until proven otherwise 
demands the utilization of rigorous empiric 
antibiotics regimens. The use of these medi-
cations is far from benign. In the ICU setting 
with all its innate risk factors for nosocomial 
infections, empiric antibiotic utilization can 
lead the patient to be unnecessarily exposed to 
courses of antibiotics with inherent toxicities, 
drug interactions and side effects that are con-
ceivably detrimental to recovery or elucidation 
of the fevers origin. Furthermore, a response 
to antibiotics is an unreliable criterion for 
diagnosing or excluding bacterial or viral CNS 
infection, especially in the context of neuro-
critical or neurosurgical patients with intrinsic 
risks for non-infectious fever anyway.
Conclusion: Treatment Implications of 
Infectious versus Non-Infectious Fever
Clinical signs of fever are frequent in neu-
rocritical and neurosurgical patients, and 
antibiotics are often administered without 
proof of infection. The clinical characteristics 
of patients with infectious fever and non-
infectious fever markedly overlap. Classical 
markers of infection cannot differentiate 
reliably between inflammation and infection 
after neurosurgery.17 The neurosurgical patient 
having suffered a CNS insult but lacking a 
documented source of fever, has a central 
neurogenic fever or post-traumatic hyper-
thermia by definition. To make the diagnosis 
of non-infectious unexplained fever (central 
neurogenic fever or post-traumatic hyperther-
mia) the clinician must have a high index of 
suspicion. On the NICU, the clinician combats 
inherent limitations of the physical exam and 
neurological exam, while racing against the 
incubation period for cultures, and exponen-
tial growth curve of infectious organisms in 
vivo. The critical sequelae of either untreated 
infections or unmanaged central neurogenic 
fever are urgent dilemmas in the neurocriti-
cal and neurosurgical intensive care setting. 
Regardless, the adverse effects of temperature 
elevation on neurological recovery are clear. 
The maxim that “time is tissue” and now 
“temp is tissue” demands further investigation 
and further trials of antipyretic medications, 
anti-hyperthermia strategies such as intravas-
cular cooling techniques in addition to surgi-
cal interventions for tissue sparing before the 
onset of further ischemic damage or coagula-
tive necrosis in the CNS. 
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